Hefei Ren
415 Fengyang Road
Shanghai, 200003, China
Shanghai, 200003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The impact of adjuvant chemotherapy on overall survival and cancer-specific survival in patients with extrahepatic cholangiocarcinoma across different age groups: a population-based study.
Journal: Journal of gastrointestinal oncology
Published: March 31, 2026
LDH-mediated autophagic full-chain blockade for Multiple Myeloma treatment by targeting circ_0008255/miR-192-5p/ATG2A axis.
Journal: Bioactive materials
Published: February 26, 2026
The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma.
Journal: Molecular and cellular probes
Published: January 13, 2026
Prognostic significance of hematological parameters and albumin in BCMA-targeted CAR-T therapy for multiple myeloma.
Journal: Frontiers in immunology
Published: September 11, 2025
DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis.
Journal: Clinical and experimental medicine
Published: December 28, 2024
Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions.
Journal: Frontiers in oncology
Published: November 21, 2024
Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study.
Journal: Frontiers in oncology
Published: November 17, 2024
TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response.
Journal: Frontiers in pharmacology
Published: October 27, 2024
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis.
Journal: Cancer cell international
Published: October 08, 2023
Unraveling the molecular crosstalk and immune landscape between COVID-19 infections and ischemic heart failure comorbidity: New insights into diagnostic biomarkers and therapeutic approaches.
Journal: Cellular signalling
Published: July 28, 2023
Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma.
Journal: Frontiers in oncology
Published: December 20, 2022
The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers.
Journal: Frontiers in immunology
Published: December 04, 2022
Last Updated: 09/26/2026